1349 related articles for article (PubMed ID: 18936569)
21. Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis.
Boardman R; Trofe J; Alloway R; Rogers C; Roy-Chaudhury P; Cardi M; Safdar S; Groene B; Buell J; Hanaway M; Thomas M; Alexander W; Munda R; Woodle ES
Transplant Proc; 2005 Mar; 37(2):817-8. PubMed ID: 15848542
[TBL] [Abstract][Full Text] [Related]
22. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
Patel SJ; Duhart BT; Krauss AG; Moore LW; Egidi MF; Amiri HS; Gaber LW; Gaber AO
Transplantation; 2008 Jul; 86(2):313-20. PubMed ID: 18645496
[TBL] [Abstract][Full Text] [Related]
24. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
25. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
Roberti I; Reisman L; Lieberman KV; Burrows L
Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
[TBL] [Abstract][Full Text] [Related]
26. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
27. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine.
Montagnino G; Sandrini S; Iorio B; Schena FP; Carmellini M; Rigotti P; Cossu M; Altieri P; Salvadori M; Stefoni S; Corbetta G; Ponticelli C
Nephrol Dial Transplant; 2008 Feb; 23(2):707-14. PubMed ID: 17890244
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic evaluation of short-term outcome after early corticosteroid discontinuation in kidney transplantation.
Miura M; Ogawa Y; Kubota KC; Harada H; Shimoda N; Seki T; Hirano T; Nonomura K
Clin Transplant; 2009 Aug; 23 Suppl 20():10-6. PubMed ID: 19594589
[TBL] [Abstract][Full Text] [Related]
29. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
[TBL] [Abstract][Full Text] [Related]
30. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
[TBL] [Abstract][Full Text] [Related]
31. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
32. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2005 Oct; 37(8):3527-30. PubMed ID: 16298650
[TBL] [Abstract][Full Text] [Related]
33. Global cardiovascular risk under early corticosteroid cessation decreases progressively in the first year following renal transplantation.
Rogers CC; Alloway RR; Boardman R; Trofe J; Hanaway MJ; Alexander JW; Roy-Chaudhury P; Buell JF; Thomas M; Susskind B; Woodle ES
Transplant Proc; 2005 Mar; 37(2):812-3. PubMed ID: 15848540
[TBL] [Abstract][Full Text] [Related]
34. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
[TBL] [Abstract][Full Text] [Related]
35. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
He X; Johnston A
Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
[TBL] [Abstract][Full Text] [Related]
36. Can daclizumab reduce acute rejection and improve long-term renal function in tacrolimus-based primary renal transplant recipients?
Cheung CY; Liu YL; Wong KM; Chan HW; Chan YH; Wong HS; Chak WL; Choi KS; Chau KF; Shek CC; Li CS
Nephrology (Carlton); 2008 Jun; 13(3):251-5. PubMed ID: 18221256
[TBL] [Abstract][Full Text] [Related]
37. Long-term renal function in cyclosporine-treated renal allograft recipients.
Tanabe K; Novick AC; Streem S; Hodge E
Urology; 1995 Sep; 46(3):321-7. PubMed ID: 7660506
[TBL] [Abstract][Full Text] [Related]
38. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.
Kee TY; Chapman JR; O'Connell PJ; Fung CL; Allen RD; Kable K; Vitalone MJ; Nankivell BJ
Transplantation; 2006 Jul; 82(1):36-42. PubMed ID: 16861939
[TBL] [Abstract][Full Text] [Related]
39. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
[TBL] [Abstract][Full Text] [Related]
40. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
